{"References": [{"title": "Lipoxins and their synthetic analogs: Therapeutic potential in inflammatory diseases", "authors": "Serhan CN, Chiang N, Dalli J", "journal": "Trends in Pharmacological Sciences", "year": "2015", "volumes": "36", "first page": "725", "last page": "744", "DOI": "10.1016/j.tips.2015.08.002"}, {"title": "Lipoxin A4 and its stable analogs inhibit inflammation by interacting with the ALX/FPR2 receptor", "authors": "Bannenberg GL, Arita M, Serhan CN", "journal": "Journal of Immunology", "year": "2004", "volumes": "172", "first page": "1573", "last page": "1579", "DOI": "10.4049/jimmunol.172.3.1573"}, {"title": "Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators", "authors": "Serhan CN, Savill J", "journal": "Nature Reviews Immunology", "year": "2005", "volumes": "5", "first page": "380", "last page": "391", "DOI": "10.1038/nri1606"}, {"title": "Lipoxins: Endogenous regulators of inflammation", "authors": "Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K", "journal": "Nature Medicine", "year": "2000", "volumes": "6", "first page": "1142", "last page": "1147", "DOI": "10.1038/80428"}, {"title": "Lipoxin A4 and aspirin-triggered lipoxin A4 inhibit airway hyper-responsiveness in a murine model of asthma", "authors": "Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt B, Szczeklik A, Drazen JM, Serhan CN", "journal": "Journal of Clinical Investigation", "year": "2002", "volumes": "109", "first page": "617", "last page": "623", "DOI": "10.1172/JCI14102"}, {"title": "Aspirin-triggered lipoxins and 15-epi-lipoxin analogs inhibit neutrophil recruitment and vascular permeability: Implications for the design of stable anti-inflammatory therapeutics", "authors": "Clish CB, Levy BD, Chiang N, Tai HH, Serhan CN", "journal": "Journal of Pharmacology and Experimental Therapeutics", "year": "2000", "volumes": "293", "first page": "1043", "last page": "1051", "DOI": "10.1124/jpet.293.3.1043"}, {"title": "Lipoxin A4 and aspirin-triggered lipoxin A4 inhibit tumor necrosis factor 1Î±-initiated neutrophil responses and trafficking: Divergent actions in TNF receptor-deficient mice", "authors": "Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR", "journal": "Journal of Immunology", "year": "2000", "volumes": "164", "first page": "1663", "last page": "1669", "DOI": "10.4049/jimmunol.164.3.1663"}, {"title": "Lipoxins and aspirin-triggered lipoxins: An overview of their biological actions and relevance to inflammation", "authors": "Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA", "journal": "Prostaglandins, Leukotrienes and Essential Fatty Acids", "year": "2003", "volumes": "69", "first page": "117", "last page": "122", "DOI": "10.1016/S0952-3278(03)00089-5"}, {"title": "The role of lipoxins and aspirin-triggered lipoxins in the resolution of inflammation", "authors": "Serhan CN, Maddox JF, Petasis NA, Akritopoulou-Zanze I, Papayianni A, Brady HR, Colgan SP, Madara JL", "journal": "Prostaglandins, Leukotrienes and Essential Fatty Acids", "year": "1997", "volumes": "57", "first page": "327", "last page": "332", "DOI": "10.1016/S0952-3278(97)90134-4"}, {"title": "Lipoxins and aspirin-triggered lipoxins: Novel lipid mediators in anti-inflammation and resolution", "authors": "Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL", "journal": "Journal of Clinical Investigation", "year": "2002", "volumes": "109", "first page": "765", "last page": "773", "DOI": "10.1172/JCI15275"}]}